Narula Sanjeev bought PHAT
October 6, 2025 · Form 4 insider transaction
Narula Sanjeev bought 200,000 shares of Phathom Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
200,000
Price
$0.00
Total value
N/A
InsiderNarula Sanjeev
RoleOfficer
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateOctober 6, 2025
Filing dateOctober 7, 2025
Shares owned after200,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The stock option will vest with respect to 25% of the shares of common stock on October 6, 2026, and will vest with respect to the remaining shares in equal monthly installments over the following three years, subject to the Reporting Person's continuous service to the Issuer on the applicable vesting dates.